# Rabeprazole Protection of Aspirin Induced Gastric Damage.

> **NCT00220857** · PHASE4 · COMPLETED · sponsor: **Temple University** · enrollment: 30 (estimated)

## Conditions studied

- Normal Subjects

## Interventions

- **DRUG:** Rabeprazole

## Key facts

- **NCT ID:** NCT00220857
- **Lead sponsor:** Temple University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2008-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00220857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00220857, "Rabeprazole Protection of Aspirin Induced Gastric Damage.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00220857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*